Humana
$388.36Change from previous close: +2.29%Absolute change: +$8.68
At a glance
- Revenue growth
- +10.11%
- 2025 vs 2024
- Net income growth
- −1.57%
- 2025 vs 2024
- Net margin
- 0.9%
- 2024: 1.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1,966 | 1,254 | -1,652 | 971 | 1,271 | — |
| Depreciation and amortization | 188 | 194 | 194 | 204 | 211 | — |
| Capital expenditure | -132 | -121 | -202 | -135 | -114 | — |
| Investing cash flow | -273 | -2,553 | 632 | 980 | 347 | — |
| Financing cash flow | 249 | 2,050 | -168 | -603 | -1,828 | — |
| Dividends paid | -107 | -107 | -109 | -107 | -106 | — |
| Share repurchases | -1.0 | -107 | -42.0 | 0.0 | -100 | — |
| Debt issued | 607 | 1,683 | 0.0 | 0.0 | 0.0 | — |
| Debt repaid | -271 | -10.0 | -279 | 5.0 | -772 | — |
| Net change in cash | 1,942 | 751 | -1,188 | 1,348 | -210 | — |
| Free cash flow | 1,834 | 1,133 | -1,854 | 836 | 1,157 | — |